{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:44:20Z","timestamp":1777527860431,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["U01AR078544"],"award-info":[{"award-number":["U01AR078544"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s13346-024-01620-y","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T19:01:41Z","timestamp":1716836501000},"page":"638-654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of 4-phenylbutyric acid microsponge gel formulations for the treatment of lewisite-mediated skin injury"],"prefix":"10.1007","volume":"15","author":[{"given":"Sharvari M.","family":"Kshirsagar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nethra","family":"Viswaroopan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meheli","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Shajid Ashraf","family":"Junaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiya","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail","family":"Muzaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritesh K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Athar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4005-5359","authenticated-orcid":false,"given":"Ajay K.","family":"Banga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"1620_CR1","unstructured":"Agency for Toxic Substances and Disease Registry CDC. ToxFAQsTM for blister agents: lewisite (L), mustard-lewisite mixture (HL) [Internet]. 2011 [cited 2024 Jan 2]. Available from: https:\/\/wwwn.cdc.gov\/TSP\/ToxFAQs\/."},{"key":"1620_CR2","doi-asserted-by":"publisher","unstructured":"Davis MJ. The dermatologic aspects of the vesicant war gases. J Am Med Assoc [Internet]. 1944;126:209\u201313. Available from: https:\/\/doi.org\/10.1001\/jama.1944.02850390007003.","DOI":"10.1001\/jama.1944.02850390007003"},{"key":"1620_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1289\/ehp.9298259","volume":"98","author":"AP Watson","year":"1992","unstructured":"Watson AP, Griffin GD. Toxicity of vesicant agents scheduled for destruction by the chemical stockpile disposal program. Environ Health Perspect. 1992;98:259\u201380.","journal-title":"Environ Health Perspect"},{"key":"1620_CR4","doi-asserted-by":"crossref","unstructured":"Goldman M, Dacre JC. Lewisite: its chemistry, toxicology, and biological effects. Rev Environ Contam Toxicol [Internet]. 1989;110:75\u2013115. Available from: https:\/\/api.semanticscholar.org\/CorpusID:5671462.","DOI":"10.1007\/978-1-4684-7092-5_2"},{"key":"1620_CR5","unstructured":"National Research Council (U.S.). Committee on Acute Exposure Guideline Levels. Acute exposure guideline levels for selected airborne chemicals. 2013. Vol 15. ISBN: 9780309291224."},{"key":"1620_CR6","unstructured":"Agency for Toxic Substances and Disease Registry, CDC. Medical management guidelines for blister agents: lewisite [Internet]. Toxic Substances Portal. 2011 [cited 2024 Apr 18]. Available from: https:\/\/wwwn.cdc.gov\/TSP\/MMG\/MMGDetails.aspx?mmgid=922&toxid=190."},{"key":"1620_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/oxfordjournals.bmb.a073250","volume":"5","author":"RA Peters","year":"1948","unstructured":"Peters RA. Development and theoretical significance of british anti-lewisite. Br Med Bull. 1948;5:4\u20135.","journal-title":"Br Med Bull"},{"key":"1620_CR8","doi-asserted-by":"publisher","unstructured":"Peters R, Stocken L, Thompson R. British anti-lewisite (BAL). Nature. 1945;156. Available from: https:\/\/doi.org\/10.1038\/156616a0.","DOI":"10.1038\/156616a0"},{"key":"1620_CR9","first-page":"38","volume":"11","author":"N Tripathi","year":"1998","unstructured":"Tripathi N, Flora S. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice. Biomed Environ Sci. 1998;11:38\u201345.","journal-title":"Biomed Environ Sci"},{"key":"1620_CR10","doi-asserted-by":"publisher","unstructured":"Flora SJS, Flora G, Saxena G. Arsenicals: Toxicity, their use as chemical warfare agents, and possible remedial measures. Handbook of Toxicology of Chemical Warfare Agents. Elsevier Inc. 2009;109\u201333. Available from: https:\/\/doi.org\/10.1016\/B978-0-12-374484-5.00009-2.","DOI":"10.1016\/B978-0-12-374484-5.00009-2"},{"key":"1620_CR11","unstructured":"Dawn L, Whited L. Dimercaprol. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549804\/."},{"key":"1620_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.taap.2013.06.012","volume":"272","author":"S Mouret","year":"2013","unstructured":"Mouret S, Wartelle J, Emorine S, Bertoni M, Nguon N, Cl\u00e9ry-Barraud C, et al. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice. Toxicol Appl Pharmacol. 2013;272:291\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1620_CR13","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1016\/j.ajpath.2016.06.012","volume":"186","author":"C Li","year":"2016","unstructured":"Li C, Srivastava RK, Weng Z, Croutch CR, Agarwal A, Elmets CA, et al. Molecular mechanism underlying pathogenesis of lewisite-induced cutaneous blistering and inflammation: chemical chaperones as potential novel antidotes. Am J Pathol. 2016;186:2637\u201349.","journal-title":"Am J Pathol"},{"key":"1620_CR14","doi-asserted-by":"publisher","unstructured":"Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. Nature Publishing Group. 2008;455\u201362. Available from:  https:\/\/doi.org\/10.1038\/nature07203.","DOI":"10.1038\/nature07203"},{"key":"1620_CR15","unstructured":"FDA. BUPHENYL \u00ae (sodium phenylbutyrate) Tablets BUPHENYL \u00ae (sodium phenylbutyrate) Powder- FDA LABEL. Available from: https:\/\/accessdata.fda.gov."},{"key":"1620_CR16","doi-asserted-by":"publisher","unstructured":"Srivastava RK, Li C, Weng Z, Agarwal A, Elmets CA, Afaq F, et al. Defining cutaneous molecular pathobiology of arsenicals using phenylarsine oxide as a prototype. Sci Rep. 2016;6:34865 Available from: https:\/\/doi.org\/10.1038\/srep34865.","DOI":"10.1038\/srep34865"},{"key":"1620_CR17","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1021\/acs.molpharmaceut.2c00636","volume":"19","author":"D Vora","year":"2022","unstructured":"Vora D, Dandekar AA, Srivastava RK, Athar M, Banga AK. Development and evaluation of a topical foam formulation for decontamination of warfare agents. Mol Pharm. 2022;19:4644\u201353.","journal-title":"Mol Pharm"},{"key":"1620_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-023-02527-6","volume":"24","author":"A Dandekar","year":"2023","unstructured":"Dandekar A, Vora D, Yeh JS, Srivastava RK, Athar M, Banga AK. Enhanced Transdermal Delivery of N-acetylcysteine and 4-phenylbutyric acid for Potential Use as Antidotes to Lewisite AAPS PharmSciTech. AAPS PharmSci Tech. 2023;24:1\u201313.","journal-title":"AAPS PharmSci Tech"},{"key":"1620_CR19","unstructured":"ChemAxon. Chemicalize-Instant Cheminformatics Solutions. 4-phenyl butyric acid [Internet]. 2023 [cited 2023 Sep 1]. Available from: https:\/\/chemicalize.com\/app\/calculation."},{"key":"1620_CR20","unstructured":"Junaid MSA. Technologies to enhance and modify delivery of small molecules into and across the skin [Internet]. Mercer University; 2022 [cited 2024 Feb 10]. Available from:\u00a0https:\/\/ursa.mercer.edu\/."},{"key":"1620_CR21","doi-asserted-by":"publisher","unstructured":"Embilt K, Nachts S. The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. 1996;13:575\u201388. https:\/\/doi.org\/10.3109\/02652049609026042.","DOI":"10.3109\/02652049609026042"},{"key":"1620_CR22","doi-asserted-by":"publisher","unstructured":"Kaity S, Maiti S, Ghosh AK, Pal D, Ghosh A, Banerjee S. Microsponges: A novel strategy for drug delivery system. J Adv Pharm Technol Res. Wolters Kluwer Medknow Publications; 2010. p. 283\u201390.\u00a0https:\/\/doi.org\/10.4103\/0110-5558.72416. PMID: 22247859; PMCID: PMC3255415.","DOI":"10.4103\/0110-5558.72416"},{"key":"1620_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijpharm.2005.11.001","volume":"308","author":"M Jelvehgari","year":"2006","unstructured":"Jelvehgari M, Siahi-Shadbad MR, Azarmi S, Martin GP, Nokhodchi A. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. Int J Pharm. 2006;308:124\u201332.","journal-title":"Int J Pharm"},{"key":"1620_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1208\/s12249-009-9220-7","volume":"10","author":"N Amrutiya","year":"2009","unstructured":"Amrutiya N, Bajaj A, Madan M. Development of microsponges for topical delivery of mupirocin. AAPS PharmSciTech. 2009;10:402\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"1620_CR25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jsps.2015.02.020","volume":"23","author":"RAM Osmani","year":"2015","unstructured":"Osmani RAM, Aloorkar NH, Ingale DJ, Kulkarni PK, Hani U, Bhosale RR, et al. Microsponges based novel drug delivery system for augmented arthritis therapy. Saudi Pharmaceutical Journal. 2015;23:562\u201372.","journal-title":"Saudi Pharmaceutical Journal"},{"key":"1620_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/0976-0105.177705","volume":"7","author":"A Moin","year":"2016","unstructured":"Moin A, Deb T, Osmani RM, Bhosale R, Hani U. Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy. J Basic Clin Pharm. 2016;7:39.","journal-title":"J Basic Clin Pharm"},{"key":"1620_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ddr.21492","volume":"80","author":"G Singhvi","year":"2019","unstructured":"Singhvi G, Manchanda P, Hans N, Dubey SK, Gupta G. Microsponge: An emerging drug delivery strategy. Drug Dev Res. 2019;80:200\u20138.","journal-title":"Drug Dev Res"},{"key":"1620_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejps.2016.09.038","volume":"96","author":"PM Kumar","year":"2017","unstructured":"Kumar PM, Ghosh A. Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. Eur J Pharm Sci. 2017;96:243\u201354.","journal-title":"Eur J Pharm Sci"},{"key":"1620_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.4155\/tde.14.43","volume":"5","author":"C Bothiraja","year":"2014","unstructured":"Bothiraja C, Gholap AD, Shaikh KS, Pawar AP. Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy. Ther Deliv. 2014;5:781\u201394.","journal-title":"Ther Deliv"},{"key":"1620_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/00963402.2004.11460769","volume":"60","author":"JA Vilensky","year":"2004","unstructured":"Vilensky JA, Sinish PR. The dew of death. B Atom Sci. 2004;60:54\u201360.","journal-title":"B Atom Sci"},{"key":"1620_CR31","doi-asserted-by":"publisher","unstructured":"Rahman MS, Hasan MS, Nitai AS, Nam S, Karmakar AK, Ahsan MS, et al. Recent developments of carboxymethyl cellulose. Polymers (Basel). MDPI AG; 2021;13(8).\u00a0https:\/\/doi.org\/10.3390\/polym13081345.","DOI":"10.3390\/polym13081345"},{"key":"1620_CR32","first-page":"235","volume":"46","author":"V Ghorpade","year":"2012","unstructured":"Ghorpade V, Mali K, Dias R, Karande P. Carbopol and sodium carboxymethylcellulose based methylsulfonylmethane gels for treatment of osteoarthritis: in-vitro and in-vivo evaluation. Indian J Pharm Educ Res. 2012;46:235\u201342.","journal-title":"Indian J Pharm Educ Res"},{"key":"1620_CR33","doi-asserted-by":"publisher","unstructured":"Shrestha N, Banga AK. Development and evaluation of transdermal delivery system of tranylcypromine for the treatment of depression. Drug Deliv Transl Res [Internet]. 2022;13:1048\u201358. Available from: https:\/\/doi.org\/10.1007\/s13346-022-01269-5.","DOI":"10.1007\/s13346-022-01269-5"},{"key":"1620_CR34","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1007\/s11095-022-03406-8","volume":"39","author":"SM Kshirsagar","year":"2022","unstructured":"Kshirsagar SM, Kipping T, Banga AK. Fabrication of polymeric microneedles using novel vacuum compression molding technique for transdermal drug delivery. Pharm Res. 2022;39:3301\u201315.","journal-title":"Pharm Res"},{"key":"1620_CR35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11095-022-03190-5","volume":"40","author":"AA Dandekar","year":"2022","unstructured":"Dandekar AA, Garimella HT, German CL, Banga AK. Microneedle mediated iontophoretic delivery of tofacitinib citrate. Pharm Res. 2022;40:735\u201347.","journal-title":"Pharm Res"},{"key":"1620_CR36","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1080\/17425247.2022.2135700","volume":"19","author":"D Vora","year":"2022","unstructured":"Vora D, Banga AK. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine. Expert Opin Drug Deliv. 2022;19:1539\u201348.","journal-title":"Expert Opin Drug Deliv"},{"key":"1620_CR37","doi-asserted-by":"publisher","unstructured":"Vora D, Dandekar A, Bhattaccharjee S, Singh ON, Agrahari V, Peet MM, et al. Formulation development for transdermal delivery of raloxifene, a chemoprophylactic agent against breast cancer. Pharmaceutics [Internet]. 2022;14(3):680. Available from:\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics14030680.","DOI":"10.3390\/pharmaceutics14030680"},{"key":"1620_CR38","doi-asserted-by":"publisher","unstructured":"Karve T, Banga AK. Comparative evaluation of physical and chemical enhancement techniques for transdermal delivery of linagliptin. Int J Pharm. 2024;654. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123992.","DOI":"10.1016\/j.ijpharm.2024.123992"},{"key":"1620_CR39","doi-asserted-by":"publisher","unstructured":"Junaid MSA, Banga AK. Transdermal delivery of baclofen using iontophoresis and microneedles. AAPS PharmSciTech [Internet]. 2022;23:84. Available from: https:\/\/doi.org\/10.1208\/s12249-022-02232-w.","DOI":"10.1208\/s12249-022-02232-w"},{"key":"1620_CR40","doi-asserted-by":"publisher","unstructured":"Mahant S, Kumar S, Nanda S, Rao R. Microsponges for dermatological applications: Perspectives and challenges. Asian J Pharm Sci. Shenyang Pharmaceutical University; 2020. p. 273\u201391.\u00a0https:\/\/doi.org\/10.1016\/j.ajps.2019.05.004.","DOI":"10.1016\/j.ajps.2019.05.004"},{"key":"1620_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40005-016-0230-7","volume":"46","author":"N Patel","year":"2016","unstructured":"Patel N, Padia N, Vadgama N, Raval M, Sheth N. Formulation and evaluation of microsponge gel for topical delivery of fluconazole for fungal therapy. J Pharm Investig. 2016;46:221\u201338.","journal-title":"J Pharm Investig"},{"key":"1620_CR42","doi-asserted-by":"publisher","unstructured":"Ma L, Guo S, Piao J, Piao M. Preparation and evaluation of a microsponge dermal stratum corneum retention drug delivery system for griseofulvin. AAPS PharmSciTech. 2022;23. Available from: https:\/\/doi.org\/10.1208\/s12249-022-02362-1.","DOI":"10.1208\/s12249-022-02362-1"},{"key":"1620_CR43","unstructured":"Vanderbilt University. Solvent Polarities [Internet]. [cited 2024 Jan 13]. Available from: www.lab.vanderbilt.edu."},{"key":"1620_CR44","unstructured":"UCLA. Solvents [Internet]. [cited 2024 Jan 13]. Available from: https:\/\/www.chem.ucla.edu\/~bacher\/General\/30BL\/tips\/solvent.html."},{"key":"1620_CR45","doi-asserted-by":"publisher","unstructured":"Andra VVSNL, Pammi SVN, Bhatraju LVKP, Ruddaraju LK. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. Bionanoscience. Springer; 2022;12:274\u201391. Available from: https:\/\/doi.org\/10.1007\/s12668-022-00941-x.","DOI":"10.1007\/s12668-022-00941-x"},{"key":"1620_CR46","doi-asserted-by":"publisher","unstructured":"Devi N, Kumar S, Prasad M, Rao R. Eudragit RS100 based microsponges for dermal delivery of clobetasol propionate in psoriasis management. J Drug Deliv Sci Technol. 2020;55. https:\/\/doi.org\/10.1016\/j.jddst.2019.101347.","DOI":"10.1016\/j.jddst.2019.101347"},{"key":"1620_CR47","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jsps.2018.01.005","volume":"26","author":"MM Obiedallah","year":"2018","unstructured":"Obiedallah MM, Abdel-Mageed AM, Elfaham TH. Ocular administration of acetazolamide microsponges in situ gel formulations. Saudi Pharmaceutical Journal. 2018;26:909\u201320.","journal-title":"Saudi Pharmaceutical Journal"},{"key":"1620_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ajps.2015.06.003","volume":"10","author":"RAM Osmani","year":"2015","unstructured":"Osmani RAM, Aloorkar NH, Thaware BU, Kulkarni PK, Moin A, Hani U, et al. Microsponge based drug delivery system for augmented gastroparesis therapy: Formulation development and evaluation. Asian J Pharm Sci. 2015;10:442\u201351.","journal-title":"Asian J Pharm Sci"},{"key":"1620_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejps.2017.12.023","volume":"114","author":"S Salah","year":"2018","unstructured":"Salah S, Awad GEA, Makhlouf AIA. Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: Formulation development and in vivo therapeutic efficacy in rats. Eur J Pharm Sci. 2018;114:255\u201366.","journal-title":"Eur J Pharm Sci"},{"key":"1620_CR50","doi-asserted-by":"publisher","unstructured":"Junqueira MV, Bruschi ML. A Review about the drug delivery from microsponges. AAPS PharmSciTech. Springer New York LLC; 2018;19:1501\u201311. Available from:  https:\/\/doi.org\/10.1208\/s12249-018-0976-5.","DOI":"10.1208\/s12249-018-0976-5"},{"key":"1620_CR51","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1208\/s12249-018-1081-5","volume":"19","author":"DBED Mahmoud","year":"2018","unstructured":"Mahmoud DBED, Shukr MH, ElMeshad AN. Gastroretentive microsponge as a promising tool for prolonging the release of mitiglinide calcium in type-2 diabetes mellitus: optimization and pharmacokinetics study. AAPS PharmSciTech. 2018;19:2519\u201332.","journal-title":"AAPS PharmSciTech"},{"key":"1620_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/261068","volume":"2015","author":"AP Pawar","year":"2015","unstructured":"Pawar AP, Gholap AP, Kuchekar AB, Bothiraja C, Mali AJ. Formulation and evaluation of optimized oxybenzone microsponge gel for topical delivery. J Drug Deliv. 2015;2015:1\u20139.","journal-title":"J Drug Deliv"},{"key":"1620_CR53","unstructured":"LibreTextsChemistry. Infrared Spectroscopy Absorption Table [Internet]. 2024 [cited 2024 Jan 7]. Available from: https:\/\/chem.libretexts.org\/Ancillary_Materials\/Reference\/Reference_Tables\/Spectroscopic_Reference_Tables\/Infrared_Spectroscopy_Absorption_Table."},{"key":"1620_CR54","doi-asserted-by":"publisher","unstructured":"Alhamhoom Y, Ravi G, Osmani RAM, Hani U, Prakash GM. Formulation, characterization, and evaluation of eudragit-coated saxagliptin nanoparticles using 3 factorial design modules. Molecules. 2022;27. Available from: https:\/\/doi.org\/10.3390\/molecules27217510.","DOI":"10.3390\/molecules27217510"},{"key":"1620_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.dit.2013.06.009","volume":"5","author":"AS Joshi","year":"2013","unstructured":"Joshi AS, Patil CC, Shiralashetti SS, Kalyane NV. Design, characterization and evaluation of Eudragit microspheres containing glipizide. Drug Invention Today. 2013;5:229\u201334.","journal-title":"Drug Invention Today"},{"key":"1620_CR56","first-page":"33","volume":"3","author":"ChN Patra","year":"2017","unstructured":"Patra ChN, Priya R, Swain S, Kumar Jena G, Panigrahi KC, Ghose D. Pharmaceutical significance of eudragit: a review. Futur J Pharm Sci. 2017;3:33\u201345.","journal-title":"Futur J Pharm Sci"},{"key":"1620_CR57","doi-asserted-by":"publisher","unstructured":"Kshirsagar S, Dandekar A, Srivastava RK, Khan J, Muzaffar S, Athar M, et al. Microneedle-mediated transdermal delivery of N-acetyl cysteine as a potential antidote for lewisite injury. Int J Pharm. 2023;647. Available from: https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123547.","DOI":"10.1016\/j.ijpharm.2023.123547"},{"key":"1620_CR58","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00396-008-1882-2","volume":"286","author":"A Benchabane","year":"2008","unstructured":"Benchabane A, Bekkour K. Rheological properties of carboxymethyl cellulose (CMC) solutions. Colloid Polym Sci. 2008;286:1173\u201380.","journal-title":"Colloid Polym Sci"},{"key":"1620_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4155\/tde-2020-0024","volume":"12","author":"D Vora","year":"2021","unstructured":"Vora D, Kim Y, Banga AK. Development and evaluation of a heparin gel for transdermal delivery via laser-generated micropores. Ther Deliv. 2021;12:133\u201344.","journal-title":"Ther Deliv"},{"key":"1620_CR60","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/app.32056","volume":"117","author":"N Roy","year":"2010","unstructured":"Roy N, Saha N, Kitano T, Saha P. Novel hydrogels of PVP-CMC and their swelling effect on viscoelastic properties. J Appl Polym Sci. 2010;117:1703\u201310.","journal-title":"J Appl Polym Sci"},{"key":"1620_CR61","unstructured":"Lubrizol Pharmaceuticals. Carbopol\u00ae 980 NF Polymer. Carbomer Homopolymer Type C USP NF[Internet]. 2024 [cited 2024 Jan 14]. Available from: https:\/\/www.lubrizol.com\/Health\/Pharmaceuticals\/Excipients\/Carbopol-Polymer-Products\/Carbopol-980-NF-Polymer."},{"key":"1620_CR62","doi-asserted-by":"publisher","unstructured":"Varges PR, Costa CM, Fonseca BS, Naccache MF, De Souza Mendes PR. Rheological characterization of carbopol \u00ae dispersions in water and in water\/glycerol solutions. Fluids. 2019;4:1\u20133. https:\/\/doi.org\/10.3390\/fluids4010003.","DOI":"10.3390\/fluids4010003"},{"key":"1620_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnnfm.2007.02.011","volume":"144","author":"JM Piau","year":"2007","unstructured":"Piau JM. Carbopol gels: elastoviscoplastic and slippery glasses made of individual swollen sponges. Meso- and macroscopic properties, constitutive equations and scaling laws. J Nonnewton Fluid Mech. 2007;144:1\u201329.","journal-title":"J Nonnewton Fluid Mech"},{"key":"1620_CR64","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1208\/s12249-016-0574-3","volume":"18","author":"AP Pandit","year":"2017","unstructured":"Pandit AP, Patel SA, Bhanushali VP, Kulkarni VS, Kakad VD. Nebivolol-loaded microsponge gel for healing of diabetic wound. AAPS PharmSciTech. 2017;18:846\u201354.","journal-title":"AAPS PharmSciTech"},{"key":"1620_CR65","doi-asserted-by":"crossref","unstructured":"Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) [Internet]. Adv Drug Deliv Rev. 2001. Available from:\u00a0www.elsevier.com\/locate\/drugdeliv.","DOI":"10.1016\/S0169-409X(01)00112-0"},{"key":"1620_CR66","doi-asserted-by":"publisher","unstructured":"Srivastava RK, Mishra B, Muzaffar S, Gorbatyuk MS, Agarwal A, Mukhtar MS, et al. Dynamic regulation of the nexus between stress granules, roquin, and regnase-1 underlies the molecular pathogenesis of warfare vesicants. Front Immunol. 2022;12. Available from: https:\/\/doi.org\/10.3389\/fimmu.2021.809365.","DOI":"10.3389\/fimmu.2021.809365"},{"key":"1620_CR67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.abb.2016.09.003","volume":"609","author":"RK Srivastava","year":"2016","unstructured":"Srivastava RK, Li C, Ahmad A, Abrams O, Gorbatyuk MS, Harrod KS, et al. ATF4 regulates arsenic trioxide-mediated NADPH oxidase, ER-mitochondrial crosstalk and apoptosis. Arch Biochem Biophys. 2016;609:39\u201350.","journal-title":"Arch Biochem Biophys"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01620-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T23:03:38Z","timestamp":1735513418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01620-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01620-y","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"1 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have read the manuscript and given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not have relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}